• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• M
• Madaan, Tushar
  University of Cincinnati
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Tushar Madaan
  Favorite
• Madden, Molly
  Edgewise Therapeutics
• (M1430-01-05) Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
  Molly Madden
  Favorite
• Malz, Alexandra
  BioNTech SE
• (M1330-01-01) Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
  Alexandra Malz
  Favorite
• Maniar, Amudhan
  Syngene International Ltd.
• (T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
  Amudhan Maniar
  Favorite
• Marino, John
  National Institute of Standards and Technology
• (M1130-01-06) Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
  John Marino
  Favorite
• Marker, Alex
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Alex Marker
  Favorite
• Martin, William
  EpiVax Inc.
• (M1030-01-04) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
  William Martin
  Favorite
• (M1130-01-05) Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
  William Martin
  Favorite
• Mavroudis, Panteleimon
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Panteleimon Mavroudis
  Favorite
• Maximov, Anton
  Neuresta
• (T1030-01-07) Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
  Anton Maximov
  Favorite
• Mayer, Andrew
  GSK plc
• (T1430-01-03) Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
  Andrew Mayer
  Favorite
• Meibohm, Bernd
  University of Tennessee Health Science Center
• (T1030-01-04) Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
  Bernd Meibohm
  Favorite
• Mekhssian, Kevork
  Altasciences
• (M1330-01-05) Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
  Kevork Mekhssian
  Favorite
• Merchant, Zahra
  Evonik Canada Inc.
• (T1130-01-05) CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
  Zahra Merchant
  Favorite
• Michel, Alexander
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Alexander Michel
  Favorite
• Montelione, Gaetano
  Rensselaer Polytechnic Institute
• (T1030-01-09) Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
  Gaetano Montelione
  Favorite
• Moreno, Zachary
  PPD, a part of Thermo Fisher Scientific
• (M1030-01-05) Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
  Zachary Moreno
  Favorite